Lasa Supergenerics Ltd.

8.93

0 (0.2%)growUp

As on February 13, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap45 Cr
P/E Ratio-2.06
Dividend YieldN/A
Trendline Performance

Unlock_ipo_icon.webpUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open9.15
High9.15
NSE SymbolLASA
Close8.93
Low8.7
BSE Symbol540702
Previous Years High/Low
1 Year High25.15
3 Year High41.2
5 Year High92.9
1 Year Low8.16
3 Year Low8.16
5 Year Low8.16

Technicals


IndicatorsValueSignal
5-DMA8.93Bullish
10-DMA8.96Bearish
20-DMA9.11Bearish
50-DMA9.53Bearish
100-DMA10.17Bearish
200-DMA11.31Bearish

Historical Performance


1 Year
-63.8%
3 Years
-68%
5 Years
-87.9%
10 Years
N/A

Shareholding Pattern


Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


Compounded Sales Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Compounded Profit Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Stock Price CAGR
10 Years:N/A
5 Years:-34.3
3 Years:-29.1
TTM:-62.3
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:N/A

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a low PE of -2.06, which may indicate undervaluation or subdued growth expectations.
  • Over the last three years, the stock delivered a weak 3-year price CAGR of -29.1%, indicating poor shareholder returns.
  • The stock carries a beta of 0.9, indicating volatility broadly in line with the market.
  • In the last financial year, the company reported an EBITDA of ₹23 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹1043 million, suggesting a mid-sized operation.

Investment Calculator


Investment Amount:

Investment Amount: ₹ 1000000
Current Value: ₹ 406463.4
No. of Shares: 45517 (Approx)
Performance:-59.4%
P/L: ₹-593536.6
NIFTY Performance: 11.1%
1 day Top Gainers
SymbolChange%
ENGINERSIN201.67(12%)
LINDEINDIA6900(7%)
SIGNATURE1040.55(6%)
VTL510.55(6%)
ABFRL73.8(5%)
1 Day Top Losers
SymbolChange%
MUTHOOTFIN3586.1(-12%)
COHANCE315.6(-10%)
BSOFT398.95(-8%)
ALKEM5402.5(-8%)
FSL254.15(-7%)
PRAJIND308.45(-7%)
ADANIPOWER139.9(-7%)
ERIS1414.4(-6%)

Top Performing Stocks from the same sector


NGL Fine-Chem Ltd.

58.6%

2277.4

1 Month Performance

Lincoln Pharmaceuticals Ltd.

36.7%

654.3

1 Month Performance

Ind-Swift Laboratories Ltd.

34.5%

136.06

1 Month Performance

Bliss GVS Pharma Ltd.

34.1%

217.82

1 Month Performance

Acutaas Chemicals Ltd.

19.9%

2017.6

1 Month Performance

Wanbury Ltd.

19.8%

254.62

1 Month Performance

Sakar Healthcare Ltd.

19.1%

446.75

1 Month Performance

Ortin Global Ltd.

15.9%

15.61

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month